Related Drugs
Isosorbide mononitrate dispersible tablets
Indication: Long-term treatment of coronary heart disease and prevention of angina pectoris; treatment of persistent angina pectoris after myocardial infarction; combined with digitalis and/or diuretics to treat chronic congestive heart failure.
Manufacturer:
Lunan BETTER Pharmaceutical Co., Ltd.
Isosorbide dinitrate tablets
Indication: Long-term treatment of coronary heart disease; prevention of angina pectoris; treatment of persistent angina pectoris after myocardial infarction; combined with digitalis and/or diuretics to treat chronic congestive heart failure.
Manufacturer:
Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.
Nifedipine
Indication: Clinically applicable to the prevention and treatment of angina pectoris caused by coronary heart disease, especially variant angina pectoris and angina pectoris caused by coronary artery spasm. Applicable to various types of hypertension, and also has good efficacy on refractory and severe hypertension. Raynaud's syndrome. Because it can reduce afterload, it also has good efficacy on refractory congestive heart failure and is suitable for long-term use. In addition, it is also suitable for patients with angina pectoris suffering from obstructive respiratory diseases, and its efficacy is better than beta-receptor blockers.
Nifedipine
Indication: Clinically applicable to the prevention and treatment of angina pectoris caused by coronary heart disease, especially variant angina pectoris and angina pectoris caused by coronary artery spasm. Applicable to various types of hypertension, and also has good efficacy on refractory and severe hypertension. Raynaud's syndrome. Because it can reduce afterload, it also has good efficacy on refractory congestive heart failure and is suitable for long-term use. In addition, it is also suitable for patients with angina pectoris suffering from obstructive respiratory diseases, and its efficacy is better than beta-receptor blockers.
Manufacturer:
Wanbangde Pharmaceutical Group Co., Ltd.
Nifedipine
Indication: Clinically applicable to the prevention and treatment of angina pectoris caused by coronary heart disease, especially variant angina pectoris and angina pectoris caused by coronary artery spasm. Applicable to various types of hypertension, and also has good efficacy on refractory and severe hypertension. Raynaud's syndrome. Because it can reduce afterload, it also has good efficacy on refractory congestive heart failure and is suitable for long-term use. In addition, it is also suitable for patients with angina pectoris suffering from obstructive respiratory diseases, and its efficacy is better than beta-receptor blockers.
Manufacturer:
Chongqing Qingyang Pharmaceutical Co., Ltd.
Nifedipine
Indication: Clinically applicable to the prevention and treatment of angina pectoris caused by coronary heart disease, especially variant angina pectoris and angina pectoris caused by coronary artery spasm. Applicable to various types of hypertension, and also has good efficacy on refractory and severe hypertension. Raynaud's syndrome. Because it can reduce afterload, it also has good efficacy on refractory congestive heart failure and is suitable for long-term use. In addition, it is also suitable for patients with angina pectoris suffering from obstructive respiratory diseases, and its efficacy is better than beta-receptor blockers.
Manufacturer:
Beijing Yanjing Pharmaceutical Co., Ltd.
Nifedipine
Indication: Clinically applicable to the prevention and treatment of angina pectoris caused by coronary heart disease, especially variant angina pectoris and angina pectoris caused by coronary artery spasm. Applicable to various types of hypertension, and also has good efficacy on refractory and severe hypertension. Raynaud's syndrome. Because it can reduce afterload, it also has good efficacy on refractory congestive heart failure and is suitable for long-term use. In addition, it is also suitable for patients with angina pectoris suffering from obstructive respiratory diseases, and its efficacy is better than beta-receptor blockers.
Manufacturer:
CSPC OUYI Pharmaceutical Co., Ltd.
Nifedipine
Indication: Clinically applicable to the prevention and treatment of angina pectoris caused by coronary heart disease, especially variant angina pectoris and angina pectoris caused by coronary artery spasm. Applicable to various types of hypertension, and also has good efficacy on refractory and severe hypertension. Raynaud's syndrome. Because it can reduce afterload, it also has good efficacy on refractory congestive heart failure and is suitable for long-term use. In addition, it is also suitable for patients with angina pectoris suffering from obstructive respiratory diseases, and its efficacy is better than beta-receptor blockers.
Manufacturer:
CSPC OUYI Pharmaceutical Co., Ltd.